Assignee
GALECTIN THERAPEUTICS INC
US14 patents
Top patents by PatentIndex Score
US8962824B2Feb 24, 2015
Composition of novel carbohydrate drug for treatment of human diseases
GALECTIN THERAPEUTICS INC11 citations91
US9974802B2May 22, 2018
Composition of novel carbohydrate drug for treatment of human diseases
GALECTIN THERAPEUTICS INC4 citations83
US9649327B2May 16, 2017
Composition of novel carbohydrate drug for treatment of human diseases
GALECTIN THERAPEUTICS INC5 citations83
US9339515B2May 17, 2016
Method for treatment of pulmonary fibrosis
GALECTIN THERAPEUTICS INC8 citations83
US9200090B2Dec 1, 2015
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC4 citations83
US8828971B2Sep 9, 2014
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
GALECTIN THERAPEUTICS INC12 citations83
US10420793B2Sep 24, 2019
Composition of novel carbohydrate drug for treatment of human diseases
GALECTIN THERAPEUTICS INC1 citations72
US9968631B2May 15, 2018
Method for treatment of pulmonary fibrosis
GALECTIN THERAPEUTICS INC2 citations72
US9763974B2Sep 19, 2017
Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
GALECTIN THERAPEUTICS INC2 citations72
US10398778B2Sep 3, 2019
Method for enhancing specific immunotherapies in cancer treatment
GALECTIN THERAPEUTICS INC3 citations69
US8367638B2Feb 5, 2013
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC1 citations62
US11413303B2Aug 16, 2022
Methods for treatment of arthritis
GALECTIN THERAPEUTICS INC0 citations61
US10799525B2Oct 13, 2020
Composition of novel carbohydrate drug for treatment of human diseases
GALECTIN THERAPEUTICS INC0 citations51
US10744154B2Aug 18, 2020
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC0 citations51